HEMATOLOGIC MALIGNANCY
Clinical trials for HEMATOLOGIC MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC MALIGNANCY trials appear
Sign up with your email to follow new studies for HEMATOLOGIC MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at childhood blood cancers
Disease control Recruiting nowThis early-phase study tests a new treatment called CD70-CAR T-cells for children and young adults (up to age 21) with blood cancers like leukemia, lymphoma, or MDS that have returned or not responded to standard therapy. The treatment involves taking the patient's own immune cel…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Apr 29, 2026 02:38 UTC
-
CAR-T Therapy's heart risk under the microscope
Knowledge-focused Recruiting nowThis study looks at whether CAR-T cell therapy, a new immune treatment for blood cancers, can cause early heart problems. Researchers will check heart function with ultrasound before and a few days after treatment in 60 patients. The goal is to find out how often heart issues hap…
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Apr 29, 2026 02:39 UTC
-
Flu shot study aims to protect kids fighting cancer
Knowledge-focused Recruiting nowThis study is for children with blood cancer who are getting the seasonal flu vaccine. Researchers want to see how their immune systems respond to the vaccine and how long protection lasts. The goal is to better understand if the flu shot works well in these children and helps pr…
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Apr 29, 2026 02:39 UTC